Gastroenterology

Gastroenterology

Volume 89, Issue 6, December 1985, Pages 1266-1278
Gastroenterology

Lipoprotein abnormalities in primary biliary cirrhosis: Association with hepatic lipase inhibition as well as altered cholesterol esterification

https://doi.org/10.1016/0016-5085(85)90642-0Get rights and content

Abstract

The nature and etiology of plasma lipoprotein abnormalities in patients with varying stages of primary biliary cirrhosis (PBC) were assessed. Two distinct lipoprotein patterns were observed. In patients with early and intermediate histologic stages of PBC, mild elevations of very low density lipoproteins and low density lipoproteins (LDLs), and marked increases in high density lipoproteins (HDLs) were often noted (group 1). In contrast, patients with advanced disease had marked elevations in LDLs with the presence of lipoprotein-X, and a significant decrease in HDLs (group 2). The lipoprotein pattern in group 1 was characterized by a normal ratio of free cholesterol to total cholesterol, whereas in group 2, this ratio was elevated. In plasma from group 1 patients only spherical micelles were observed on electron microscopy, whereas in plasma from group 2 patients bilayered disks could be seen in LDLs and HDLs. The increase in HDLs observed in group 1 subjects was associated with elevations in HDL2, whereas in group 2 subjects only very low amounts of HDL3 were observed on analytic ultracentrifugation. Mean plasma apolipoprotein B and C-II concentrations were increased in both groups; but apolipoprotein A-I and A-II values were divergent, with group 1 subjects having elevated values, and group 2 subjects having decreased values. Mean postheparin hepatic lipase activity was decreased in both groups of patients with PBC due to the presence of an inhibitor in PBC plasma, while altered cholesterol esterification was only observed in group 2. These data indicate that hepatic lipase inhibition may play an important role in the pathogenesis of the lipoprotein abnormalities seen in early and intermediate PBC, and these abnormalities are then further modified by altered cholesterol esterification in advanced disease.

References (63)

  • HB Brewer et al.

    The amino acid sequence of human apoA-I, an apolipoprotein isolated from high density lipoproteins

    Biochem Biophys Res Commun

    (1978)
  • JK Huttunen et al.

    An immunological method for selective measurement of two triglyceride lipases in human post heparin plasma

    Clin Chim Acta

    (1975)
  • P Nilsson-Ehle et al.

    A stable, radioactive substrate emulsion for assay of lipoprotein lipase

    J Lipid Res

    (1976)
  • P Belfrage et al.

    Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides

    J Lipid Res

    (1969)
  • TM Forte et al.

    Application of electron microscopy to the study of plasma lipoprotein structure

    Adv Lipid Res

    (1972)
  • J Grosser et al.

    Function of hepatic triglyceride lipase in lipoprotein metabolism

    (1981)
  • K Shirai et al.

    Hydrolysis of human plasma high density lipoproteins—phospholipids and triglycrides by hepatic lipase

    Biochem Biophys Res Commun

    (1981)
  • CE Jahn et al.

    In vitro activation of the enzymic activity of hepatic lipase by apolipoprotein A-II

    FEBS Lett

    (1981)
  • S Sherlock

    Primary biliary cirrhosis

  • B Kapelman et al.

    The natural history of primary biliary cirrhosis

  • PJ Scheuer

    Biliary disease and cholestasis

  • H Popper et al.

    Nonsuppurative destructive cholangitis and chronic hepatitis

  • SP James et al.

    The role of the immune response in the pathogenesis of primary biliary cirrhosis

  • ER Dickson et al.

    Primary biliary cirrhosis

  • EM Russ et al.

    Lipoproteins in primary biliary cirrhosis

    J Clin Invest

    (1956)
  • EH Ahrens et al.

    Relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis

    J Clin Invest

    (1949)
  • D Seidel et al.

    A lipoprotein characterizing obstructive jaundice. I. Method for quantitation, separation and identification of lipoproteins in jaundiced subjects

    J Clin Invest

    (1969)
  • D Seidel et al.

    A lipoprotein characterizing obstructive jaundice. II. Isolation and particle characterization of the protein moieties of low density lipoproteins

    J Clin Invest

    (1971)
  • E Manzato et al.

    Formation of lipoprotein-X. Its relation to bile compounds

    J Clin Invest

    (1976)
  • RL Hamilton et al.

    Cholestasis: lamellar structure of the abnormal human serum lipoproteins

    Science

    (1971)
  • T Forte et al.

    The ultrastructure of plasma lipoproteins in lecithin: cholesterol acyltransferase deficiency

    Scand J Clin Lab Invest

    (1974)
  • Cited by (150)

    • Metabolite profiles of Pulicaria crispa and P. incisa in relation to their in-vitro/ in-vivo antioxidant activity and hepatoprotective effect: A comparative mass spectrometry-based metabolomics

      2021, Journal of Pharmaceutical and Biomedical Analysis
      Citation Excerpt :

      Both Pulicaria extracts were comparable to each other in terms of their antioxidant potential with only a slight better activity observed for P. incisa in accordance with in vitro antioxidant results. This activity is probably attributed to the presence of a myriad of antioxidants to scavenge reactive oxygen species generated after CPZ administration [33]. UPLC/MS analysis confirmed the enrichment of both Pulicaria in antioxidants compounds such as flavonoids especially methoxylated derivatives with enhanced metabolic stability and pharmacokinetic profile [18].

    • Cholestatic Liver Diseases: A Primer for Generalists and Subspecialists

      2020, Mayo Clinic Proceedings
      Citation Excerpt :

      Elevation of serum bilirubin typically occurs with progression of disease and constitutes a poor prognostic sign73 Lipid abnormalities are common in PBC. Mild elevations in low-density lipoprotein (LDL) with more marked elevations in high-density lipoprotein (HDL) are common in early PBC, whereas more prominent elevations in LDL and lower HDL levels are noted in later stages of the disease.74 Despite this, hyperlipidemia does not appear to confer excess cardiovascular risk.75

    • Hyponatremia in the cancer patient

      2020, Kidney International
    View all citing articles on Scopus
    1

    Dr. C. E. Jahn's present address is Department of Ophthalmology, University Hospital, University of Bonn, Bonn, West Germany.

    2

    Dr. C. E. Jahn was supported by a grant from the Deutsche Forschungs Gemeinschaft (DFG) of West Germany.

    View full text